Glaukos Corporation Glaukos Corporation

Glaukos Corporation

GKOS

Classement en actions #1967
Glaukos Corporation operates as an ophthalmic medical technology and... Glaukos Corporation operates as an ophthalmic medical technology and pharmaceutical enterprise, primarily focused on pioneering novel therapies for glaucoma, corneal disorders, and retinal diseases. The company offers a range of micro-bypass stents, including iStent, iStent inject, and iStent inject W. These devices are designed to enhance aqueous humor outflow, being inserted during cataract surgery to treat mild-to-moderate open-angle glaucoma. Its promising product pipeline features iStent Infinite, a three-stent system intended for standalone use in patients with refractory glaucoma, as well as iDose TR, a targeted injectable implant that utilizes Glaukos's micro-scale device platform to deliver therapeutic levels of medication. The company distributes its products through a direct sales organization and a network of distributors, serving markets across the United States and internationally. Glaukos Corporation, founded in 1998, is headquartered in San Clemente, California.
Prix de l'action
$177.09
Dernière synchronisation: 2026-10-21
Capitalisation boursière
$10.45B
Changement (1 jour)
1.76%
Changement (1 an)
131.10%
Pays
US
Échange Glaukos Corporation (GKOS)

Catégorie

Healthcare
Historique du prix de l'action pour Glaukos Corporation (GKOS)
Prix de clôture le plus élevé : $166.80 le 2026-10-01

Prix de clôture le plus bas : $29.05 le 2015-06-01
Historique du prix de l'action de Glaukos Corporation de 2015 à 2026
Performance annuelle du prix de l'action
Année Performance
2026 (TTM) 16.37%
2025 -22.38%
2024 97.91%
2023 64.84%
2022 1.09%
2021 -38.87%
2020 24.29%
2019 -5.51%
2018 133.10%
2017 -22.73%
2016 38.93%
2015 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
$100.56 -21.41%
US
$93.07 -2.95%
IE
$297.13 -23.49%
US
$44.47 -57.18%
US
$46.91 -18.13%
DE